GlassScriptPhysician profile
Canty Wang
NPI 1881072346
$13,062.40
in general payments reported to CMS, 2019-2025
14 companies · $716 in 2025
The $716 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12K · 2023: $19.96 · 2024: $146 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,058.76 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $315.73 | 2024-2025 | |
| Hologic Sales and Service, LLC | $250.48 | 2024-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $124.95 | 2022 | |
| Sumitomo Pharma America, INC. | $46.01 | 2025 | Myfembree |
| Sage Therapeutics, LLC | $45.07 | 2025 | Zurzuvae |
| Pfizer INC. | $41.22 | 2024-2025 | |
| Millicent US INC | $39.02 | 2025 | Intrarosa, Femlyv |
| Boston Scientific Corporation | $31.00 | 2024 | Advantage System |
| Bayer Healthcare Pharmaceuticals INC. | $29.99 | 2025 | |
| Applied Medical Resources Corporation | $26.67 | 2024 | Gelpoint V-Path |
| Becton, Dickinson and Company | $21.46 | 2024 | Bd Onclarity |
| Ethicon US, LLC | $19.96 | 2023 | Surgiflo Hemostatic Matrix, Dermabond Prineo, Vistaseal |
| Evofem Biosciences, INC. | $12.08 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Canty Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.